Riskpilot← Back to searchSign inGet full accessXkout Bioscience AB
ABActiveOrg 5591021695Sagoliden 8Research and experimental development on natural sciences and engineering · NACE 7210Est. 20170 employees
Revenue 2024
SEK -1
EBITDA margin
906100.0%
-7% vs 2023
Equity ratio
91.7%
Financial strength
Net profit 2024
SEK 19K
+8091% vs 2023
| Revenue | SEK -1 | — |
| EBITDA | SEK -9K | -7% |
| Net profit | SEK 19K | +8091% |
| Total assets | SEK 314K | -2% |
| Equity | SEK 288K | +7% |
| Employees | 0 | — |
Legal name
Xkout Bioscience AB
Org number
5591021695
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
27 februari 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Aktiebolaget ska bedriva rådgivning, utbildning och uthyrning av operationella tjänster inom läkemedelsutveckling, utveckling av medicintekniska produkter och digitala hälsoprodukter, samt därmed förenlig verksamhet.
Address
Sagoliden 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | 241 | 1 | 20 | 7 | 0 | 0 | −0 |
| Staff expenses | — | — | — | — | — | — | — | — |
| EBITDA | 206 | 164 | −19 | −7 | −13 | −17 | −8 | −9 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | — | — | — |
| EBIT | 206 | 164 | −19 | −7 | −13 | −17 | −8 | −9 |
| Net financials | — | −1 | 7 | — | 3 | 6 | 4 | 3 |
| Profit before tax | 161 | 123 | −1 | −1 | 0 | 1 | 1 | 25 |
| Tax | −36 | −27 | −0 | −0 | −0 | −0 | −1 | −6 |
| Net profit | 125 | 96 | −1 | −1 | 0 | 0 | 0 | 19 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 286 | 498 | 387 | 360 | 345 | 327 | 320 | 314 |
| Equity | 175 | 271 | 270 | 269 | 269 | 269 | 269 | 288 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | — | — | — |
| Short-term debt | 66 | 142 | 43 | 23 | 19 | 12 | 11 | 17 |
| Total debt | 66 | 142 | 43 | 23 | 19 | 12 | 11 | 17 |
EBITDA margin
-906100.0%
This company
15.8%
Market median
-5734910% vs market
20172024
Equity ratio
91.7%
This company
38.2%
Market median
+140% vs market
20172024
Return on equity
6.6%
This company
18.4%
Market median
-64% vs market
20172024
Net profit margin
1900400.0%
This company
8.1%
Market median
+23461628% vs market
20172024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20172024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-02-01 – 2017-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Xkout Bioscience AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Andreas Linderoth Norlin | Chairman | 0 companies |
| Lars Ulf Anders Linderoth | Deputy Board Member | 0 companies |
| Ann Catarina Linderoth | Board of Directors | 0 companies |